Share Name Share Symbol Market Type
Sanofi EU:SAN Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 94.89 93.61 94.50 0.00 06:15:07

European Medicines Agency Approves Additional Manufacturing Sites for Pfizer-BioNTech Covid Vaccine

09/09/2021 5:56pm

Dow Jones News

Sanofi (EU:SAN)
Historical Stock Chart

From Jul 2021 to Jan 2022

Click Here for more Sanofi Charts.
   By Giulia Petroni 

The European Medicines Agency said Thursday that it has approved two additional manufacturing sites for the production of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE.

The sites, which will manufacture the finished product, are set to provide up to 50 million additional doses of Comirnaty by 2021, according to the EU agency.

One site is operated by Sanofi-Aventis Deutschland GmbH, while the other by Siegfried Hameln GmbH. They are both located in Germany.

The European Medicines Agency said the sites can become operational immediately, as the recommendation doesn't require a decision from the European Commission.


Write to Giulia Petroni at giulia.petroni@wsj.com


(END) Dow Jones Newswires

September 09, 2021 12:41 ET (16:41 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Sanofi Chart

1 Year Sanofi Chart

1 Month Sanofi Chart

1 Month Sanofi Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220128 06:58:03